Literature DB >> 32220767

Do lifetime anxiety disorders (anxiety liability) and pregnancy-related anxiety predict complications during pregnancy and delivery?

Jana Hoyer1, Gesine Wieder2, Michael Höfler3, Linda Krause4, Hans-Ulrich Wittchen5, Julia Martini6.   

Abstract

BACKGROUND: Evidence suggests that maternal anxiety is associated with adverse pregnancy and delivery outcomes, such as preterm birth, vaginal bleedings and low birth weight. AIMS: To examine the association of lifetime anxiety disorders and pregnancy-related anxiety and complications during pregnancy and delivery. STUDY
DESIGN: Prospective-longitudinal study (MARI).
SUBJECTS: N = 306 pregnant women who were investigated repeatedly during the peripartum period. OUTCOME MEASURES: Information on lifetime anxiety disorders was assessed using a dimensional score (lifetime anxiety liability index) based on the standardized Composite International Diagnostic Interview for Women (CIDI-V). Pregnancy-related anxiety was surveyed with the Pregnancy and Childbirth Related Fears (PCF) questionnaire. Common pregnancy (e.g. vaginal bleedings) and delivery complications (e.g. labor induction) were assessed via medical records, interviews and questionnaires.
RESULTS: The global tests on the association between lifetime anxiety liability and pregnancy complications and on the association between pregnancy-related anxiety and pregnancy/delivery complications revealed significant associations. Further analyses revealed associations of lifetime anxiety liability with preterm labor (OR = 1.6, 95% CI = 1.2-2.0) as well as pregnancy-related anxiety with vaginal bleedings (OR = 1.4, 95% CI = 1.0-1.8), preterm labor (OR = 1.3, 95% CI = 1.0-1.7), gestational diabetes (OR 0.5, 95% CI = 0.2-0.9), labor induction (OR = 1.5, 95% CI = 1.1-1.9) and use of labor medication (OR = 1.6, 95% CI = 1.2-2.0). After adjustment for maternal age, maternal body mass index, maternal smoking, socioeconomic status (occupation, household income) and social support (cohabitation), the associations between pregnancy-related anxiety and labor induction as well as use of labor medication remained significant.
CONCLUSIONS: Pregnancy-related anxiety should be regularly assessed and, if necessary, treated during (early) pregnancy to minimize risks for complications during delivery.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Delivery complications; Maternal anxiety; Pregnancy complications; Preterm labor; Vaginal bleedings

Year:  2020        PMID: 32220767     DOI: 10.1016/j.earlhumdev.2020.105022

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  5 in total

1.  Controlling the anxiety in Iranian pregnant women at risk of preterm labor by undergoing the counseling group intervention.

Authors:  Somayeh Bazrafshan; Masoomeh Kheirkhah; Mehrnoosh Inanlou; Mahboobeh Rasouli
Journal:  J Family Med Prim Care       Date:  2020-08-25

2.  Manifestation and Associated Factors of Pregnancy-Related Worries in Expectant Fathers.

Authors:  Ariane Göbel; Petra Arck; Kurt Hecher; Michael Schulte-Markwort; Anke Diemert; Susanne Mudra
Journal:  Front Psychiatry       Date:  2020-12-11       Impact factor: 4.157

3.  Designing architecture of soothing labor-delivery-recovery-postpartum unit: a study protocol.

Authors:  Behnam Kazemi Esfeh; Ashraf Kazemi; Aida Shamsaie
Journal:  Reprod Health       Date:  2020-12-10       Impact factor: 3.223

4.  Personality impacts fear of childbirth and subjective birth experiences: A prospective-longitudinal study.

Authors:  Eva Asselmann; Susan Garthus-Niegel; Julia Martini
Journal:  PLoS One       Date:  2021-11-03       Impact factor: 3.240

5.  Behavioral Inhibition in the Second Year of Life Is Predicted by Prenatal Maternal Anxiety, Overprotective Parenting and Infant Temperament in Early Infancy.

Authors:  Susanne Mudra; Ariane Göbel; Eva Möhler; Lydia Yao Stuhrmann; Michael Schulte-Markwort; Petra Arck; Kurt Hecher; Anke Diemert
Journal:  Front Psychiatry       Date:  2022-06-03       Impact factor: 5.435

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.